Partner Organizations

ImClone Systems Incorporated

ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (NYSE:LLY), is committed to advancing oncology care by developing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. Norwich is pleased to offer ImClone Systems Incorporated employees and their families a 10% tuition discount and waived application fee for our master’s degree programs.